Immune checkpoint inhibitor-induced diabetes mellitus: clinical characteristics and risk factors

Immune checkpoint inhibitor-induced diabetes mellitus: clinical characteristics and risk factors

BackgroundEmerging evidence indicates that immune checkpoint inhibitor-induced diabetes mellitus (ICI-DM) might be more common than initially reported, and more different clinical pictures associated with ICI-DM were described.ObjectiveThe aim of our study was to identify the clinical characteristic...

Full description

Saved in:
Bibliographic Details
Main Authors: Mei Zhan, Qinran Long, Jinhan He, Litao Huang, Bin Wu, Haixia Xu, Li Mo, Ting Xu
Format: Article
Language:English
Published: Frontiers Media S.A. 2025-01-01
Series:Frontiers in Immunology
Subjects:
immune checkpoint inhibitors
diabetes mellitus
immune-related adverse events
cancer
immunotherapy
Online Access:https://www.frontiersin.org/articles/10.3389/fimmu.2025.1499074/full
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items

Similar Items